AT-001
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for AT-001, covering 2014-01-23 to 2022-12-08. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AT-001 in Patients With Diabetic Cardiomyopathy [Phase 3]